Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

North China Pharmaceutical Co Ltd Announces Change in Shareholding Structure


Wednesday, 17 Jul 2013 08:00pm EDT 

North China Pharmaceutical Co Ltd announced that Jizhong Energy Group Co., Ltd. (Jizhong Group) has signed a subscription agreement with the Company on July 17, 2013, to subscribe 250 million A shares of the Company in private placement at RMB 4.53 per share. After the subscription, Jizhong Group's stake in the Company will increase from 25.39% to 36.84%, while its indirect holdings in the Company through its wholly owned subsidiary, North China Pharmaceutical Group Corporation, will decrease from 20.80% to 17.61%. Thus Jizhong Group's total holdings in the Company will increase from 46.19% to 54.45%. 

Company Quote

6.69
0.07 +1.06%
23 Oct 2014